• Advanced Biophysical Characterization of Lipid Nanoparticles

  2026-04-30

  This study presents a rigorous, multi-technique approach to characterizing lipid nanoparticles (LNPs) used for mRNA delivery, revealing substantial heterogeneity in particle size, shape, and mRNA loading. These findings have direct implications for optimizing formulations and predicting transfection efficiency in both research and clinical applications.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Pr

  2026-04-29

  DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe provides robust, high-contrast labeling of plasma membranes for cell migration, neuronal tracing, and membrane dynamics assessment in live and fixed specimens. It is specifically designed for lipid bilayer staining and should not be used for organelle-specific labeling or in aqueous protocols. Careful adherence to solubility and membrane compatibility parameters is essential for reproducibility.

• Chlorpromazine Hydrochloride in Antipsychotic & Hepatic Rese

  2026-04-29

  Discover how chlorpromazine hydrochloride empowers reliable dopaminergic and hepatic nanoparticle research with actionable protocols and troubleshooting strategies. Learn to optimize your workflow using APExBIO’s high-purity compound, backed by recent advances in neuropharmacology and nanomedicine.

• Optimizing Protein Analysis with Prestained Protein Marker (

  2026-04-28

  This scenario-driven article demonstrates how the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) (SKU F4005) from APExBIO addresses reproducibility, compatibility, and data integrity challenges in SDS-PAGE and Western blot workflows. Drawing on real laboratory scenarios and literature-backed evidence, we provide actionable guidance for scientists seeking reliable molecular weight standards.

• SCUBE3 Antibody Targeting Suppresses Tumor Progression and I

  2026-04-28

  This study identifies secretory protein SCUBE3 as a crucial driver of cancer cell survival, therapy resistance, and tumor immune evasion. It demonstrates that antibody-mediated inhibition of SCUBE3 disrupts oncogenic signaling, impairs DNA repair, and restores antitumor immunity, marking a significant advance toward pan-cancer therapeutic strategies.

• Systemic Impact of Epinephrine Dosage in Dental Anesthesia

  2026-04-27

  This review dissects how varying concentrations of epinephrine, a non-selective adrenergic receptor agonist, influence the efficacy and systemic effects of local anesthetics in dental practice. It establishes the optimal concentration for balancing anesthetic duration, safety, and adverse effect risk, with translational implications for cardiovascular and sympathetic nervous system research.

• Exosomal Egr2 from BMSCs Mitigates Ischemic Neuronal Injury

  2026-04-27

  This study uncovers how exosomal Egr2 derived from bone marrow mesenchymal stem cells (BMSCs) protects neurons against oxygen-glucose deprivation/reoxygenation (OGD/R) injury, a model of ischemic stroke. Mechanistically, Egr2 regulates the RNF8/DAPK1 axis, offering new insights into neuroprotective signaling with implications for targeted stroke therapies.

• Hydroxytyrosol: Concentration-Dependent Bioactivity in Cardi

  2026-04-26

  Explore the distinct, concentration-dependent mechanisms of Hydroxytyrosol—a powerful phenolic antioxidant—for cardiovascular health research. This article unveils new insights into assay design and translational applications, grounded in recent advances and product innovation.

• BFH772 (VEGFR2 inhibitor): Protocols, Use, and QC Guidance

  2026-04-25

  BFH772 is a potent, selective VEGFR2 inhibitor for researchers targeting VEGFR2-mediated angiogenesis, particularly in tumor growth models. It is not suitable for workflows requiring water-soluble compounds or broad-spectrum kinase inhibition due to its defined solubility and selectivity profiles.

• Phosbind Biotin LC: Practical Guide for Phosphorylated Prote

  2026-04-24

  Phosbind Biotin LC enables sensitive, sequence-independent detection of phosphorylated proteins in Western Blot workflows. It provides a reliable alternative to phospho-specific antibodies, particularly where sequence context is unknown or such antibodies are unavailable. This reagent should not be used in aqueous-only protocols or workflows requiring long-term stock solution storage.

• Intranasal Epinephrine in Dogs: Pharmacokinetics and Heart R

  2026-04-24

  This study evaluates the pharmacokinetics and cardiac response of intranasal versus intramuscular epinephrine in canine models. The findings demonstrate rapid systemic absorption and reduced heart rate impact with intranasal delivery, supporting its potential as an alternative emergency intervention in anaphylaxis.

• Integrative Protocols for (-)-Epinephrine (+)-bitartrate in

  2026-04-23

  Explore the nuanced use of Epinephrine Bitartrate as a non-selective adrenergic receptor agonist in translational cardiology and neurobiology. This article uniquely bridges high-resolution protocol design and comparative evidence, providing actionable insights for advanced sympathetic nervous system research.

• Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO): Technica

  2026-04-23

  The Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) safeguards protein samples during extraction by inhibiting a broad range of endogenous proteases without compromising mass spectrometry compatibility. It is ideal for workflows requiring robust protein degradation prevention but is not suitable for metalloproteinase inhibition unless supplemented with EDTA.

• DDX21-NAT10-ac4C Axis Drives Metastasis in Colorectal Cancer

  2026-04-22

  This study uncovers how DDX21 enhances colorectal cancer metastasis and angiogenesis by upregulating NAT10, which increases ac4C mRNA modification and stability of pro-metastatic transcripts. The findings provide a mechanistic link between RNA modification and tumor progression, highlighting the DDX21/NAT10 axis as a potential therapeutic target.

• Directed Induction of RV-like Cardiomyocytes from hPSCs: Adv

  2026-04-22

  Saito et al. present a refined differentiation protocol enabling the specific induction of right ventricular (RV)-like cardiomyocytes from human pluripotent stem cells (hPSCs). This work clarifies chamber-specific cardiac lineage allocation and creates a platform for disease modeling of RV pathologies, highlighting methodological advances relevant for cardiac research.

11311 records 1/755 page Next 12345 下5页 Last page